Skip to main content
Equibles
ENSG logo

ENSG · Ensign Group, Inc · Metrics

Track ENSG — free

Use ENSG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENSG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$188.41 +1.87 (+1.00%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.99B
Shares
58.34M
Volume · Nov 13 254.78K Avg daily vol (3M) 352.82K

ENSG metrics

111 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$188.41
Market cap
$10.99B

Price action

23 metrics
Price change (1W)
+4.0%
Price change (30D)
+5.8%
Price change (3M)
+3.7%
Price change (6M)
+6.0%
Price change (YTD)
+8.2%
Price change (1Y)
+6.3%
Trailing year
Price change (5Y)
+129.3%
52-week high
$215.83
52-week low
$147.13
Change from 52-week high
-12.7%
Change from 52-week low
+28.1%
Annualized volatility
29.8%
Annualized volatility (3M)
28.8%
Implied volatility (30D)
24.3%
IV rank (1Y)
19.1
IV percentile (1Y)
12.2
Beta
0.0
RSI (14D)
60.4
Price vs SMA 50
+6.7%
Price vs SMA 200
+3.5%
Avg volume (3M)
352,818
Relative volume
0.7
Average dollar volume
$62.36M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
58.34M

Valuation

12 metrics
P / E (TTM)
28.0
Trailing earnings · reciprocal yield 3.6%
PEG ratio
1.2
EV / revenue
1.9×
reciprocal yield 52.5%
EV / EBITDA
17.1×
reciprocal yield 5.8%
EV / EBIT
21.2×
reciprocal yield 4.7%
P / sales
1.9×
reciprocal yield 51.6%
P / book
4.3
reciprocal yield 23.3%
FCF yield
—
TTM · current market cap
Buyback yield
0.4%
P / FCF
—
P / operating cash flow
15.8
reciprocal yield 6.3%
Earnings yield
3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
29.9×
reciprocal yield 3.3%
P / E historical average (5Y)
26.8×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.7%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 58.3%
EV / EBIT historical average (3Y)
23.2×
reciprocal yield 4.3%
EV / EBIT historical average (5Y)
20.2×
reciprocal yield 4.9%
EV / EBITDA historical average (3Y)
18.5×
reciprocal yield 5.4%
EV / EBITDA historical average (5Y)
16.3×
reciprocal yield 6.1%

Dividends & buybacks

7 metrics
Dividend yield
0.1%
Trailing 12 months
Payout ratio
3.8%
Shareholder yield
0.6%
Dividend / share (TTM)
$0.26
Dividend growth YoY
+3.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
21.2%
Operating margin
9.0%
Trailing 12 months
Net margin
7.0%
Gross profit (TTM)
$1.20B
Operating profit (TTM)
$509.16M
Net income (TTM)
$399.12M
Trailing 12 months
Diluted EPS (TTM)
$6.72
FCF margin
—
Effective tax rate
25.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$95.46
Gross profit per diluted share (TTM)
$20.23
Operating profit per diluted share (TTM)
$8.57
EBITDA per diluted share (TTM)
$10.59
Net income per diluted share (TTM)
$6.71
Operating cash flow per diluted share (TTM)
$11.71
Free cash flow per diluted share (TTM)
$2.15
Capital expenditures per diluted share (TTM)
$1.28
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.04
Book value per share
$38.42

Growth

11 metrics
Revenue growth YoY
+14.5%
Year over year
Net income growth YoY
+24.4%
Revenue (TTM)
$5.67B
Trailing 12 months
EPS growth YoY
+23.9%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+18.7%
Revenue CAGR (5Y)
+16.1%
EPS CAGR (3Y)
+13.9%
EPS CAGR (5Y)
+13.8%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.6%
Return on assets
6.7%
Debt / equity
0.1
Current ratio
1.2
EBITDA (TTM)
$629.73M
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
62.8
Net debt / EBITDA
-0.3
Return on invested capital
16.1%
Trailing 12 months
Net cash
$192.97M
Latest balance sheet
Cash & equivalents
$337.59M
Total assets
$6.00B
Total debt
$198.72M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$695.67M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$62.03M
R&D / revenue
—
Stock compensation / revenue
1.1%

Ownership (13F)

9 metrics
13F filers
556
13F filer change QoQ
-24
Institutional ownership
91.4%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
21.6%
Private-fund adviser ownership
19.8%
Active holders' share change QoQ
+2.8%
Holder tenure
15.4
Price vs estimated holder cost
+5.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.6%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$17,962
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1125376 CUSIP 29358P101 13F (30d) 463 filings 417 filers Visit website Investor relations